Analysis of the Electroencephalogram (EEG) during anesthesia using remimazolam and remifentanil
- Conditions
- External causes of morbidity and mortality
- Registration Number
- KCT0006846
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 30
1.Patients between 20 and 80 years of age
2.A patient scheduled for regular surgery under general anesthesia in the operating room E rosette of Asan Medical Center, Seoul
3.Patients belonging to the American Society of Anesthesiology Classification 1, 2, or 3
4. Those who voluntarily agreed in writing to participate in this clinical study
1. Cardiovascular disease, respiratory disease, kidney disease, endocrine disease, blood disease (hemorrhagic predisposition), central nervous system disease, mental disease, Or if there is a history of meningitis or other abnormalities (refer to laboratory test values)
2. After taking central nervous system drugs (ketamine, amphetamine, midazolam, opioid, chlorpromazine, clozapine, olanzapine, risperidone, haloperidol, quetiapine, risperidone, paliperidone, amisulpride, sertindole), the elimination half-life of each drug multiplied by 5 patient
3. Patients judged inappropriate by other researchers
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Calculation of Approximate Entropy for EEG Changes Following Remimazolam Administration;Frequency analysis (Fourier transform and bispectral analysis) for EEG changes following remimazolam administration
- Secondary Outcome Measures
Name Time Method The correlation between the bispectral index, brain anesthesia response monitoring index, and changes in the patient's level of consciousness according to the administration of remimazolam